Cellectis SA (STU:ZVAA)
€ 1.48 -0.03 (-1.99%) Market Cap: 148.13 Mil Enterprise Value: -4.47 Mil PE Ratio: 0 PB Ratio: 1.47 GF Score: 49/100

Q3 2022 Cellectis SA Earnings Call Transcript

Nov 04, 2022 / 12:00PM GMT
Release Date Price: €2.14 (-3.60%)
Operator

Greetings, and welcome to the Cellectis Third Quarter 2022 Earnings Conference Call. (Operator Instructions). As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Arthur Stril, Chief Business Officer. Thank you, sir. You may begin.

Arthur Stril
Cellectis S.A. - Chief Business Officer

Good morning, and welcome, everyone, to Cellectis' Third Quarter 2022 Corporate Update and Financial Results Conference Call. Joining me on the call today with prepared remarks are Dr. Andre Choulika, our Chief Executive Officer; Dr. Bing Wang, our Chief Financial Officer; and Dr. Mark Frattini, our Chief Medical Officer. Yesterday evening, Cellectis filed its interim report and issued a press release reporting its financial results for the third quarter and 9-month period ended September 30th, 2022. The report and press release are available on our website at cellectis.com.

As a reminder, we will make statements regarding Cellectis' financial outlook in addition to its manufacturing, regulatory and product development

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot